ArticleFrontiers in medicine2026
17q12 deletion syndrome presenting with chronic pancreatitis: a case report.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: 17q12 deletion syndrome is a rare autosomal dominant disorder classically characterized by renal cystic disease, maturity-onset diabetes of the young type 5 (MODY5), and Müllerian duct anomalies (e. g., MRKH syndrome). Case presentation: Pancreatic manifestations in this syndrome commonly include congenital structural abnormalities (e.g., dorsal agenesis) or atrophy, whereas classic chronic pancreatitis is rarely documented. We report an 18-year-old female with recurrent upper abdominal pain, steatorrhea, and dyspepsia. Imaging revealed pancreatic atrophy with calcifications. Whole-exome sequencing confirmed a diagnosis of 17q12 deletion syndrome. Conclusion: This case is the first to identify chronic pancreatitis as a significant clinical phenotype of 17q12 deletion syndrome. By integrating a literature review, we discuss the pathophysiology related to hepatocyte nuclear factor 1β (HNF1B) haploinsufficiency, suggesting that chronic pancreatitis may constitute part of the syndrome's clinical spectrum.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.